Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines
NCT ID: NCT02059941
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
780 participants
OBSERVATIONAL
2012-09-30
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this proposal is to create and test guidelines for the treatment of severe TBI in the absence of ICP monitoring.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracranial Pressure (ICP) Monitoring Following Traumatic Brain Injury (TBI)
NCT04428970
Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring
NCT02773862
Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage
NCT02172703
Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience
NCT03721003
ICP Threshold After Decompressive Craniectomy
NCT06083792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this project is to create guidelines for the treatment of severe TBI in the absence of ICP monitoring and test them. We propose to derive these guidelines by working with a team of clinicians that practice in austere environments in low-to-middle income countries (LMICs) and routinely make decisions based either on a treatment protocol, their clinical experience, or both. We will use a new, systematic and innovative technology and process to accomplish consensus for the guidelines among the clinicians. We will implement the Consensus-Based Guidelines (CBG) in resource-poor centers, some of which have prior exposure to less well developed ad hoc protocols for treatment of TBI, and others that do not have prior exposure. We will test the influence of the CBG on outcomes of severe TBI in a before/after design in these two sets of centers. In the first two years, patients will be treated according to the ad hoc protocol or according to individual clinician best judgment. Then the Guidelines will be developed, all sites will be trained in their use, and they will be used to guide treatment in all sites for the next 2 years. .We will evaluate the effect of using an ad hoc protocol by comparing outcomes between the two sets of centers before the Guidelines are developed. In each set of centers we will evaluate the effect of using the consensus-based guideline protocol compared to either no protocol or the ad hoc protocol by comparing the outcomes in the first and second periods. Finally, we will evaluate how much more the consensus-based protocol effects outcome than the ad hoc protocol by comparing the difference from the first to the second period between the two sets of sites
In accomplishing the study objectives, we will create and test a guideline for the treatment of severe TBI that could be used globally to improve outcomes for these patients. We will validate in LMICs a new, systematic and innovative technology and process to accomplish consensus that was derived in an HIC. Finally, we will train personnel in centers new to research in how to conduct high-quality scientific studies, and will extend the training for the personnel with whom we have been working, solidifying previous capacity-building efforts, and initiating new efforts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Post-resuscitation Glasgow Coma Scale score (GCS) ≤ 8, and GCS Motor score ≤ 5, or Deterioration to those values within 48 hours of injury
* Age 13 years or older
* Consent to participate signed by Legally Authorized Representative (LAR)
Exclusion Criteria
* Prisoner
* No consent
* Non-survivable injury
* Other (e.g., Pre-injury life expectancy under 1 year)
* Pre-existing neurological disability that would not allow follow-up
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randall M. Chesnut
Professor, Neurological Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randall M Chesnut, MD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Viedma
Cochabamba, , Bolivia
Hospital Japones
Santa Cruz de la Sierra, , Bolivia
Hospital San Juan de Dios
Santa Cruz de la Sierra, , Bolivia
Hospital San Juan de Dios
Tarija, , Bolivia
Fundacion Clinica Campbell
Barranquilla, , Colombia
Clinica Universitaria Rafael Uribe
Cali, , Colombia
Hospital Erasmo Meoz #1
Cúcuta, , Colombia
Hospital Erasmo Meoz #2
Cúcuta, , Colombia
Hospital Jose Carrasco Arteaga
Cuenca, , Ecuador
Hospital Espejo
Quito, , Ecuador
Hospital Luis Razetti
Barcelona, , Venezuela
Hospital Luis Razetti
Barinas, , Venezuela
Hospital Dr. Patrocinio Penuela Ruiz
Cristobal, , Venezuela
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Luis A Lavadenz, MD
Role: primary
Victor Alanis, MD
Role: primary
Roberto M Merida, MD
Role: primary
Ricardo Romero, MD
Role: primary
Oscar Pinillos, MD
Role: primary
Zulma Urbina, MD
Role: primary
Jairo Figeroa, MD
Role: primary
Soraya Puertas, MD
Role: primary
Manuel E Jibaja, MD
Role: primary
Jacobo Mora, MD
Role: primary
Rafael Davila
Role: primary
Giannina B Martinez, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Alali AS, Temkin N, Barber J, Pridgeon J, Chaddock K, Dikmen S, Hendrickson P, Videtta W, Lujan S, Petroni G, Guadagnoli N, Urbina Z, Chesnut RM. A clinical decision rule to predict intracranial hypertension in severe traumatic brain injury. J Neurosurg. 2018 Sep 28;131(2):612-619. doi: 10.3171/2018.4.JNS173166. Print 2019 Aug 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
44679
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.